Skip to main content

Table 2 Bacteriostatic activity of oxacillin and glycopeptides

From: Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: Looking for a relationship between tolerance and outcome

Antibiotics

Macromethod MICs N.susceptible/N.tested (%)

E-test MICs N.susceptible/N.tested (%)

□Oxacillin (MIC: S≤2 mg/l) (DISK:S≥22 mm)

49/62 (79.0%)

49/62 (79.0%)

*/**Vancomycin (S≤2 mg/l)

60/62 (96.7%)

61/62 (98.3%)

*Teicoplanin (S≤8 mg/l)

62/62 (100%)

62/62 (100%)

**Teicoplanin (S≤2 mg/l)

60/62 (96.7%)

60/62 (96.7%)

  1. â–¡ CLSI and EUCAST susceptibility break point, cefoxitin disk diffusion same results as oxacillin
  2. *CLSI susceptibility break point
  3. **EUCAST susceptibility break point